D. Crowther

发表

ChlVPP/EVA hybrid versus the weekly VAPEC-B regimen for previously untreated Hodgkin's disease.

T. Lister, R. Gupta, Jenny C. Chang, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data

D. Crowther, 1997, The Lancet.

A predictive model for aggressive non-Hodgkin's lymphoma.

Emili Montserrat, Christian Gisselbrecht, Carlo Tondini, 1993, The New England journal of medicine.

Interferon in the treatment of multiple myeloma and the non-Hodgkin's lymphomas.

D. Crowther, J. Wagstaff, J. Howard Scarffe, 1985, Cancer treatment reviews.

Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trial.

J. Radford, D. Deakin, P. Wilkinson, 1992, Blood.

Expression of O6-alkylguanine-DNA-alkyltransferase in situ in ovarian and Hodgkin's tumours.

D. Crowther, G. Margison, A. McGown, 1993, European journal of cancer.

Studies of lectin binding to normal and neoplastic lymphoid tissues. I. Normal nodes and Hodgkin's disease.

D. Crowther, V. Bramwell, J. Gallagher, 1982, British Journal of Cancer.

Inactivation of O6-alkylguanine-DNA alkyltransferase in human peripheral blood mononuclear cells by temozolomide.

D. Crowther, G. Margison, N. Thatcher, 1994, British Journal of Cancer.

Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data

D. Crowther, 1997, The Lancet.

Haemopoietic cell kinetics in humans treated with rGM‐CSF

J. Chang, D. Crowther, T. Dexter, 1992, International journal of cancer.

Cyclophosphamide decreases O6-alkylguanine-DNA alkyltransferase activity in peripheral lymphocytes of patients undergoing bone marrow transplantation.

D. Crowther, G. Margison, R. Elder, 1992, British Journal of Cancer.

A randomised dose intensity study in ovarian carcinoma comparing chemotherapy given at four week intervals for six cycles with half dose chemotherapy given for twelve cycles.

D. Crowther, M. Ranson, C. H. Buckley, 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

Factors affecting remission and survival in patients with advanced hodgkin's disease treated with MVPP

D. Deakin, P. Wilkinson, D. Crowther, 1986, Hematological oncology.

The management of Hodgkin's disease.

J. Radford, D. Crowther, G. Morgenstern, 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

A randomized study comparing chemotherapy alone with chemotherapy followed by radiotherapy in patients with pathologically staged IIIA Hodgkin's disease.

D. Deakin, P. Wilkinson, D. Crowther, 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Management of high-grade non-Hodgkin's lymphoma in adults.

D. Crowther, J. Wagstaff, 1987, Bailliere's clinical haematology.

A randomised trial investigating the dose intensity of primary chemotherapy in patients with ovarian carcinoma: a comparison of chemotherapy given every four weeks with the same chemotherapy given at three week intervals.

G. Jayson, J. Radford, D. Crowther, 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

Combination chemotherapy for acute lymphoblastic leukaemia in adults.

J. E. Freeman, T. Lister, D. Crowther, 1978, British medical journal.

A randomized trial of two types of adjuvant chemotherapy in radiotherapy-treated patients with clinical stages I and II high-grade non-Hodgkin's lymphoma

D. Deakin, P. Wilkinson, D. Crowther, 2004, Cancer Chemotherapy and Pharmacology.

A multivariate analysis of factors affecting survival in patients with high-grade histology non-Hodgkin's lymphoma.

P. Wilkinson, D. Crowther, I. Todd, 1984, European journal of cancer & clinical oncology.

Intensive combination chemotherapy with vincristine, adriamycin and prednisolone (VAP) in the treatment of diffuse histology non-Hodgkin's lymphoma. (A report of 89 cases with extensive disease from the Manchester Lymphoma Group).

D. Deakin, P. Wilkinson, D. Crowther, 1980, European journal of cancer.

CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas: a phase II multicenter study. European Study Group of CAMPATH-1H Treatment in Low-Grade Non-Hodgkin's Lymphoma.

G. Brittinger, D. Huhn, U. Jaeger, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

New approaches to the management of patients with non-Hodgkin's lymphoma of high-grade pathology. First Gordon Hamilton-Fairley memorial lecture.

D. Crowther, 1981, British Journal of Cancer.

A phase II study of human rDNA alpha-2 interferon in patients with low grade non-Hodgkin's lymphoma

D. Crowther, J. Wagstaff, P. Loynds, 2004, Cancer Chemotherapy and Pharmacology.

Human lymphocyte traffic assessed by indium-111 oxine labelling: clinical observations.

D. Crowther, N. Thatcher, J. Wagstaff, 1981, Clinical and experimental immunology.

Maintenance chlorambucil after CVP in the management of advanced stage, low‐grade histologic type non‐Hodgkin's lymphoma: A randomized prospective study with an assessment of prognostic factors

D. Deakin, D. Crowther, L. McWilliam, 1988, Cancer.

Chemotherapy (MVPP) for Stage IIIB/IV Hodgkin’s disease with an assessment of prognostic factors

D. Crowther, I. Todd, J. Wagstaff, 1985 .

A prospective study of the treatment of high-grade histology non-Hodgkin's lymphoma involving the gastrointestinal tract.

D. Deakin, D. Crowther, I. Todd, 1985, European journal of cancer & clinical oncology.

Survival benefit from high-dose therapy with autologous blood progenitor-cell transplantation in poor-prognosis non-Hodgkin's lymphoma.

D. Deakin, P. Wilkinson, D. Crowther, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Haemopoietic growth factor and dose intensity in high-grade and intermediate-grade lymphoma.

D. Crowther, R. Pettengell, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

Granulocyte-macrophage colony stimulating factor (GM-CSF) after high-dose melphalan in patients with advanced colon cancer.

J. Radford, J. Chang, D. Crowther, 1990, British Journal of Cancer.

11-WEEK COURSE OF SEQUENTIAL METHOTREXATE, THORACIC IRRADIATION, AND MODERATE-DOSE CYCLOPHOSPHAMIDE FOR "LIMITED"-STAGE SMALL-CELL BRONCHOGENIC CARCINOMA A Study from the Manchester Lung Tumour Group

P. Wilkinson, D. Crowther, N. Thatcher, 1982, The Lancet.

P-glycoprotein expression in ovarian tumour biopsies taken before or after cytotoxic chemotherapy

T. Tsuruo, D. Crowther, A. McGown, 1992 .

Glutathione S-transferase activity and isoenzyme distribution in ovarian tumour biopsies taken before or after cytotoxic chemotherapy.

D. Crowther, A. McGown, B. Fox, 1992, British journal of cancer.

A method for following human lymphocyte traffic using indium-111 oxine labelling.

D. Crowther, N. Thatcher, J. Wagstaff, 1981, Clinical and experimental immunology.

Transplantation potential of hematopoietic cells released into the circulation during routine chemotherapy for non-Hodgkin's lymphoma.

D. Crowther, T. Dexter, R. Pettengell, 1993, Blood.

The effect of ifosfamide and its metabolites on intracellular glutathione levels in vitro and in vivo.

D. Crowther, M. Lind, N. Thatcher, 1989, Biochemical pharmacology.

Advanced recurrent squamous cell carcinoma of the head and neck. Results of a chemotherapeutic regimen with adriamycin, bleomycin, 5‐fluorouracil, methotrexate, and vitamin A

D. Crowther, N. Thatcher, G. Blackledge, 1980, Cancer.

The effect of the GM‐CSF/IL‐3 fusion protein PIXY321 on bone marrow and circulating haemopoietic cells of previously untreated patients with cancer

M. Ghielmini, D. Crowther, R. Pettengell, 1996, British journal of haematology.

Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer.

D. Crowther, T. Dexter, N. Thatcher, 1987, British Journal of Cancer.

Combined modality management of local and disseminated adult soft tissue sarcomas: a review of 257 cases seen over 10 years at the Christie Hospital & Holt Radium Institute, Manchester.

D. Deakin, D. Crowther, V. Bramwell, 1985, British Journal of Cancer.

Granulocyte-macrophage colony-stimulating factor allows safe escalation of dose-intensity of chemotherapy in metastatic adult soft tissue sarcomas: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.

D. Crowther, J. Verweij, T. Tursz, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized comparison of progenitor-cell mobilization using chemotherapy, stem-cell factor, and filgrastim or chemotherapy plus filgrastim alone in patients with ovarian cancer.

J. Radford, P. Wilkinson, J. Chang, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A study of ovarian cancer patients treated with dose-intensive chemotherapy supported with peripheral blood progenitor cells mobilised by filgrastim and cyclophosphamide.

J. Chang, D. Crowther, T. Dexter, 1996, British Journal of Cancer.

Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis

J. Radford, D. Crowther, P. Woll, 1993 .

Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis.

D. Crowther, P. Woll, R. Pettengell, 1993, Blood.

Comparative intraperitoneal pharmacokinetics of three platinum analogues

D. Crowther, C. Mcauliffe, M. Lind, 2004, Cancer Chemotherapy and Pharmacology.

In vitro and in vivo analysis of the effects of recombinant human granulocyte colony-stimulating factor in patients.

D. Crowther, T. Dexter, N. Thatcher, 1988, British Journal of Cancer.

Carcinosarcoma of the ovary treated over a 10-year period at the Christie Hospital

D. Crowther, J. Prendiville, D. Murphy, 1993, International Journal of Gynecologic Cancer.

Glutathione content of ovarian tumour biopsies taken before and after cytotoxic chemotherapy

D. Crowther, A. McGown, B. Fox, 1993 .

Viridans streptococcal bacteraemia in patients with haematological and solid malignancies.

A. Howell, D. Crowther, N. Thatcher, 1991, European journal of cancer.

DNA content in high and intermediate grade non-Hodgkin's lymphoma-prognostic significance and clinicopathological correlations.

R. Cowan, D. Crowther, M. Jones, 1989, British Journal of Cancer.

Follow up policy after treatment for Hodgkin's disease: too many clinic visits and routine tests? A review of hospital records

J. Radford, D. Crowther, C. Woodman, 1997, BMJ.

Glutathione-S-transferase activity and isoenzyme levels measured by two methods in ovarian cancer, and their value as markers of disease outcome.

D. Crowther, A. McGown, A. Mcgown, 1996, British Journal of Cancer.

A phase I study of recombinant human interleukin-4 administered by the intravenous and subcutaneous route in patients with advanced cancer: immunological studies.

P. Stern, D. Crowther, A. Ghosh, 1993, European cytokine network.

Failure to preserve fertility in patients with Hodgkin's disease

T. Lister, W. Gregory, D. Crowther, 2004, Cancer Chemotherapy and Pharmacology.

Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma.

B. Coiffier, T. Lister, M. Shipp, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

Intermittent high‐dose cyclophosphamide with and without prednisolone. A study of the relationships between toxicity, response and survival in metastatic lung cancer

D. Crowther, N. Thatcher, J. Wagstaff, 1982, Cancer.

Immunotherapy for acute myelogenous leukemia.

T. Lister, D. Crowther, T. Mcelwain, 1975, Bibliotheca haematologica.

Establishment of a murine leukaemia cell line resistant to the growth-inhibitory effect of bryostatin 1.

D. Crowther, A. Dickson, A. Gescher, 1994, British Journal of Cancer.

Immunotherapy for acute myelogenous leukaemia: a controlled clinical study 2 1/2 years after entry of the last patient.

T. Lister, D. Crowther, T. Oliver, 1977, British Journal of Cancer.

Treatment of lymphoid cell malignancy with In-114m labelled autologous lymphocytes.

R. Cowan, D. Crowther, S. Owens, 1997, Anticancer research.

In vivo depletion of O6-alkylguanine-DNA-alkyltransferase in lymphocytes and melanoma of patients treated with CB 10-277, a new DTIC analogue

D. Crowther, G. Margison, N. Thatcher, 2004, Cancer Chemotherapy and Pharmacology.

Immunomodulation in patients receiving intravenous Bryostatin 1 in a phase I clinical study: comparison with effects of Bryostatin 1 on lymphocyte function in vitro

G. Jayson, P. Stern, D. Crowther, 1994, Cancer Immunology, Immunotherapy.

trial neutropenia in non-Hodgkin's lymphoma: a randomized controlled Granulocyte colony-stimulating factor to prevent dose-limiting

D. Deakin, P. Wilkinson, R. James, 2011 .

Infection risk in patients with small cell lung cancer receiving intensive chemotherapy and recombinant human granulocyte-macrophage colony-stimulating factor

J. Radford, D. Crowther, N. Thatcher, 1992 .

Recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF) given as daily short infusions--a phase I dose-toxicity study.

D. Crowther, N. Thatcher, W. Steward, 1989, British Journal of Cancer.

Recombinant human interleukin-4 (rhu IL-4) administered by the intravenous and subcutaneous routes in patients with advanced cancer--a phase I toxicity study and pharmacokinetic analysis.

P. Stern, D. Crowther, A. Ghosh, 1993, European journal of cancer.

Bryostatin 1-tamoxifen combinations show synergistic effects on the inhibition of growth of P388 cells in vitro.

G. Jayson, D. Crowther, T. Ward, 1998, British Journal of Cancer.

MVPP chemotherapy regimen for advanced Hodgkin's disease

T. Lister, J. Peto, A. Stansfeld, 1978, British medical journal.

Activity of JM9 in advanced ovarian cancer: a phase I-II trial.

A. Howell, D. Crowther, V. Bramwell, 1985, Cancer treatment reports.

The effects of Hodgkin's disease and combination chemotherapy on gonadal function in the adult male

D. Crowther, I. Todd, S. Shalet, 1982, Cancer.

Increased Numbers of Progenitor Cells in the Apheresis Product of Patients Randomised to Receive Increasing Doses of Stem Cell Factor (r-metHuSCF) Administered in Combination with Chemotherapy and a Standard Dose of Filgrastim (r-metHuG-CSF)

D. Crowther, T. Dexter, P. Woll, 1998 .

Prognostic factors for survival in stage IIIB and IV Hodgkin's disease: a multivariate analysis comparing two specialist treatment centres.

T. Lister, W. Gregory, D. Crowther, 1988, British Journal of Cancer.

Studies of lectin binding to normal and neoplastic lymph nodes. II. Non-Hodgkin's lymphoma.

D. Crowther, V. Bramwell, J. Gallagher, 1982, British Journal of Cancer.

The significance of residual mediastinal abnormality on the chest radiograph following treatment for Hodgkin's disease.

D Crowther, J. Radford, R. Cowan, 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chemotherapy in advanced ovarian cancer: an overview of randomised clinical trials. Advanced Ovarian Cancer Trialists Group.

D. Alberts, M. Buyse, L. Stewart, 1991, BMJ.

Original article: Five year follow-up and dose delivery analysis of cisplatin, iproplatin or carboplatin in combination with cyclophosphamide in advanced ovarian carcinoma

D. Crowther, M. Ranson, C. H. Buckley, 1990 .

Five year follow-up and dose delivery analysis of cisplatin, iproplatin or carboplatin in combination with cyclophosphamide in advanced ovarian carcinoma.

D. Crowther, M. Ranson, C. H. Buckley, 1990, Annals of oncology : official journal of the European Society for Medical Oncology.

The effect of combination chemotherapy on ovarian function in women treated for hodgkin's disease

D. Crowther, I. Todd, S. Shalet, 1983, Cancer.

Immunohistochemical detection of mutant p53 protein in epithelial ovarian cancer using polyclonal antibody CMI: correlation with histopathology and clinical features.

D. Crowther, J. Norton, A. McGown, 1994, British Journal of Cancer.

Blood clearance of three radioactively labelled platinum complexes: cis-dichlorodiammine platinum II, cis, trans-dichlorodihydroxy-bis-(isopropylamine) platinum IV, and cis-dichloro-bis-cyclopropylamine platinum II, in patients with malignant disease

D. Crowther, N. Thatcher, B. Fox, 2004, Cancer Chemotherapy and Pharmacology.

In vivo distribution studies of radioactively labelled platinum complexes; cis-dichlorodiammine platinum(II), cis-trans-dichlorodihydroxy-bis-(isopropylamine) platinum (IV), cis-dichloro-bis-cyclopropylamine platinum(II), and cis-diammine 1,1-cyclobutanedicarboxylate platinum(II) in patients with ma

D. Crowther, N. Thatcher, S. Owens, 2004, Cancer Chemotherapy and Pharmacology.

Reduced bone mineral density in men following chemotherapy for Hodgkin's disease.

R. Whitehouse, J. Adams, D. Crowther, 1994, British Journal of Cancer.

Spinal-cord compression in myeloma.

D. Crowther, M. Palmer, I. Todd, 1979, British medical journal.

VAD chemotherapy—toxicity and efficacy—in patients with multiple myeloma and other lymphoid malignancies

J. Chang, D. Crowther, R. Swindell, 1987, Hematological oncology.

Clinical oncology: case presentations from oncology centres. Intensive treatment of poor prognosis gastrointestinal lymphoma.

D. Crowther, R. Pettengell, P. Bishop, 1992, European journal of cancer.

Treatment of relapsed non-Hodgkin's lymphoma with a combination of hydroxyurea, ifosfamide, and etoposide.

D. Crowther, J. Wagstaff, W. Steward, 1985, Cancer treatment reports.

The long-term effects of MVPP chemotherapy for Hodgkin's disease on bone marrow function.

J. Radford, D. Crowther, N. Testa, 1990, British Journal of Cancer.

Blood clearance of radioactively labelled cis-diammine 1,1-cyclobutane dicarboxylate platinum(II) (CBDCA) in cancer patients

D. Crowther, N. Thatcher, S. Owens, 2004, Cancer Chemotherapy and Pharmacology.

Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials. Advanced Ovarian Cancer Trialists' Group.

D. Alberts, W. Sauerbrei, M. Buyse, 1998, British Journal of Cancer.

Gastrointestinal involvement with myeloma.

D. Crowther, B. Houwen, J. Howard Scarffe, 1983, Medical and pediatric oncology.

Male fertility after VAPEC-B chemotherapy for Hodgkin's disease and non-Hodgkin's lymphoma.

J. Radford, D. Crowther, S. Shalet, 1994, British Journal of Cancer.

Serum glycoprotein hormone alpha sub-unit values and survival in metastatic melanoma patients.

D. Crowther, N. Thatcher, R. Swindell, 1979, European journal of cancer.

Malignant melanoma in children and adolescents

D. Crowther, M. Palmer, N. Thatcher, 1981, Cancer.

Lymphocyte function related to survival curves in patients with metastatic melanoma treated by chemoimmunotherapy.

D. Crowther, M. Palmer, N. Thatcher, 1978, Medical and pediatric oncology.

Lymphocyte function and response to chemo-immunotherapy in patients with metastatic melanoma.

D. Crowther, M. Palmer, N. Thatcher, 1977, British Journal of Cancer.

Effects of repeated Corynebacterium parvum and BCG therapy on immune parameters: a weekly study of melanoma patients II. Changes in serum immunoglobulins and lymphoid cell subpopulations.

D. Crowther, N. Thatcher, R. Swindell, 1979, Clinical and experimental immunology.

Effects of Corynebacterium parvum and BCG therapy on immune parameters in patients with disseminated melanoma. A sequential study over 28 days. II. Changes in non-specific (NK, K and T cell) lymphocytoxicity and delayed hypersensitivity skin reactions.

D. Crowther, N. Thatcher, R. Swindell, 1979, Clinical and experimental immunology.

A phase I study of intravenous bryostatin 1 in patients with advanced cancer.

P. Stern, D. Crowther, P. Woll, 1993, British Journal of Cancer.

Lymphocyte function in the blood of patients with untreated non-Hodgkin lymphoma: influence of stage and pathology.

D. Crowther, N. Thatcher, N. Gasiunas, 1977, Medical and pediatric oncology.

Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: A trial of the European Organization for Research and Treatment of

J. Blay, S. Rodenhuis, M. van Glabbeke, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effects of intermittent 5-fluorouracil and adriamycin on various immune parameters in carcinoma patients with reference to the tumour load

D. Crowther, N. Thatcher, M. Moore, 1977, Cancer Immunology, Immunotherapy.

A phase I trial of bryostatin 1 in patients with advanced malignancy using a 24 hour intravenous infusion.

G. Jayson, P. Stern, D. Crowther, 1995, British Journal of Cancer.

Gonadal function following chemotherapy for Hodgkin's disease: a comparative study of MVPP and a seven-drug hybrid regimen.

J. Radford, D. Crowther, S. Shalet, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Relationship between the pretreatment proliferative activity of marrow blast cells and prognosis of acute lymphoblastic leukaemia of childhood

D. Crowther, M. Palmer, J. Lilleyman, 1980, British Journal of Cancer.

Relationships between the formation of O6-methyldeoxyguanosine by 1-p-carboxyl-3,3-dimethylphenyltriazene in DNA and O6-alkylguanine-DNA alkyltransferase in human peripheral leukocytes.

D. Crowther, D. Cooper, G. Margison, 1994, Cancer research.

Pyrosequencing-based methods reveal marked inter-individual differences in oncogene mutation burden in human colorectal tumours

D. Crowther, R. Steele, F. Carey, 2011, British Journal of Cancer.

Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2,185 patients treated with anthracycline-containing first-line regimens--a European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study.

M. van Glabbeke, D. Crowther, J. Verweij, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting.

M Tubiana, D Crowther, E Glatstein, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Meta-analysis of chemotherapy versus combined modality treatment trials in Hodgkin's disease. International Database on Hodgkin's Disease Overview Study Group.

V. Diehl, R. Fisher, D. Crowther, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

VAC (vincristine, adriamycin, cyclophosphamide) chemotherapy for metastatic carcinoma from an unknown primary site.

D. Crowther, N. Thatcher, J. Wagstaff, 1983, European journal of cancer & clinical oncology.

Immunotherapy for Acute Myelogenous Leukaemia

T. Lister, D. Crowther, P. Wrigley, 1973, British Journal of Cancer.

Immunotherapy of Acute Myeloblastic Leukemia in Man

D. Crowther, G. Fairley, P. Alexander, 1974 .

Effects of Corynebacterium parvum and BCG therapy on immune parameters in patients with disseminated melanoma a sequential study over 28 days. I. Changes in blood counts, serum immunoglobulins and lymphoid cell populations.

D. Crowther, N. Thatcher, R. Swindell, 1979, Clinical and experimental immunology.

The Migratory Properties of Indium‐111 Oxine Labelled Lymphocytes in Patients with Chronic Lymphocytic Leukaemia

D. Crowther, N. Thatcher, J. Wagstaff, 1981, British journal of haematology.

Effects of diphenylhydantoin on killer cell activity and other immunological functions. A sequential study including the interaction of Corynebacterium parvum in melanoma patients.

P. Wilkinson, D. Crowther, N. Thatcher, 1982, International journal of immunopharmacology.

Lymphocyte Cytotoxicity in Melanoma Patients Undergoing Immunotherapy

D. Crowther, M. Palmer, N. Thatcher, 1979 .

Factors influencing prognosis in adults with acute myelogenous leukaemia.

D. Crowther, M. Beard, C. Bateman, 1975, British Journal of Cancer.

Primary Carcinoma of the Fallopian Tube: Favourable Response to New Chemotherapeutic Agent, CHIP

D. Crowther, V. Bramwell, J. Wagstaff, 1985, Journal of the Royal Society of Medicine.

Cancer—Principles and Practice of Oncology. V

D. Crowther, D. Crowther, 1982, British Journal of Cancer.

A randomised study of adjuvant MVPP chemotherapy after mantle radiotherapy in pathologically staged IA-IIB Hodgkin's disease: 10-year follow-up.

J. Radford, W. Ryder, D. Deakin, 1991, Annals of oncology : official journal of the European Society for Medical Oncology.

An analysis of prognostic factors in stage III and IV Hodgkin's disease treated at a single centre with MVPP.

J. Radford, D. Deakin, P. Wilkinson, 1991, Annals of oncology : official journal of the European Society for Medical Oncology.

A reliable approach for sequencing clone-specific CDRIII regions in B-cell lymphoma.

D. Crowther, T. Dexter, B. Emmerich, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

Chemotherapy of Cancer Dissemination and Metastasis

D. Crowther, 1976, British Journal of Cancer.

Chemoimmunotherapy for metastatic malignant melanoma using vincristine (NSC-67574), DTIC (NSC-45388) and Bacillus Calmette-Guerin.

D. Crowther, M. Palmer, N. Thatcher, 1981, European journal of cancer.

Interferon-alpha 2b in the treatment of follicular lymphoma: preliminary results of a trial in progress.

T. Lister, A. Rohatiner, D. Deakin, 1991, Annals of oncology : official journal of the European Society for Medical Oncology.

Bone marrow involvement in adult soft tissue sarcomas.

J. Chang, D. Crowther, V. Bramwell, 1982, European journal of cancer & clinical oncology.

Changes in cellular immunity following nephrectomy for localized and metastatic hypernephroma.

D. Crowther, N. Thatcher, R. Barnard, 1977, European journal of cancer.

Recombinant human granulocyte colony-stimulating factor (filgrastim) following high-dose chemotherapy and peripheral blood progenitor cell rescue in high-grade non-Hodgkin's lymphoma: clinical benefits at no extra cost.

J. Radford, W. Ryder, D. Crowther, 1998, British Journal of Cancer.

Increased numbers of long-term culture-initiating cells in the apheresis product of patients randomized to receive increasing doses of stem cell factor administered in combination with chemotherapy and a standard dose of granulocyte colony-stimulating factor.

D. Crowther, T. Dexter, N. Testa, 1996, Blood.

The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancer.

A. Howell, D. Crowther, T. Dexter, 1989, British Journal of Cancer.

Report of the first workshop on prognostic factors in large-cell lymphomas.

J. Armitage, B. Coiffier, M. Shipp, 1991, Annals of oncology : official journal of the European Society for Medical Oncology.

High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma group.

O. S. Nielsen, M. van Glabbeke, D. Crowther, 1998, British Journal of Cancer.

Comparison of combined and single-agent chemotherapy in non-Hodgkin's lymphoma of favourable histological type.

T. Lister, A. Stansfeld, D. Crowther, 1978, British medical journal.

Results of a randomized trial comparing MVPP chemotherapy with a hybrid regimen, ChlVPP/EVA, in the initial treatment of Hodgkin's disease.

A. Oza, R. Gupta, J. Radford, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Should high-dose chemotherapy be used in the treatment of soft tissue sarcoma?

D. Crowther, J. Verweij, P. Reichardt, 1997, European journal of cancer.

Moderate to high dose cyclophosphamide and intercalated Corynebacterium parvum in patients with metastatic lung cancer.

D. Crowther, N. Thatcher, J. Wagstaff, 1984, British journal of diseases of the chest.

Effects of repeated Corynebacterium parvum and BCG therapy on immune parameters: a weekly sequential study of melanoma patients. I. Changes in non-specific (NK, K and T cell) lymphocytotoxicity, peripheral blood counts and delayed hypersensitivity reactions.

D. Crowther, N. Thatcher, R. Swindell, 1979, Clinical and experimental immunology.

Phase II trial of temozolomide in low-grade non-Hodgkin's lymphoma.

D. Crowther, E. Newlands, P. Woll, 1995, British Journal of Cancer.

Prognostic factors in high and intermediate grade non-Hodgkin's lymphoma.

J. Radford, D. Deakin, R. Cowan, 1989, British Journal of Cancer.

The prognostic significance of mediastinal bulk in patients with stage IA-IVB Hodgkin's disease: a report from the Manchester Lymphoma Group.

D. Deakin, D. Crowther, M. Palmer, 1985, Clinical radiology.

Interferon alfa-2b in addition to chlorambucil in the treatment of follicular lymphoma: preliminary results of a randomized trial in progress.

T. Lister, A. Rohatiner, D. Deakin, 1991, European journal of cancer.

Treatment of relapsed Hodgkin's disease using a weekly chemotherapy of short duration: results of a pilot study in 20 patients.

J. Radford, D. Crowther, 1991, Annals of oncology : official journal of the European Society for Medical Oncology.

significance andclinicopathologi cal correlations

R. Cowan, D. Crowther, M. Jones, 1989 .

Prognostic factors for disease progression in advanced Hodgkin's disease: an analysis of patients aged under 60 years showing no progression in the first 6 months after starting primary chemotherapy.

J. Radford, W. Ryder, D. Deakin, 1997, British Journal of Cancer.

Phase I-II evaluation of acronine in patients with multiple myeloma.

D. Crowther, J. Howard Scarffe, A. Beaumont, 1983, Cancer treatment reports.

Peripheral blood progenitor cell (PBPC) transplantation with a single apheresis

D. Deakin, D. Crowther, R. Pettengell, 1993 .

A comparative study of the nodular and diffuse variants of lymphocyte-predominant Hodgkin's disease.

J. Radford, D. Crowther, M. Harris, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase I study of recombinant interferon gamma administered by s.c. injection three times per week in patients with solid tumours

D. Crowther, J. Wagstaff, P. Loynds, 2004, Cancer Immunology, Immunotherapy.

The pre-treatment proliferative activity of non-Hodgkin's lymphoma cells.

D. Crowther, J. Howard Scarffe, 1981, European journal of cancer.

Prognostic factors in stage I and II high and intermediate grade non-Hodgkin's lymphoma.

D. Deakin, R. Cowan, D. Crowther, 1988, European journal of cancer & clinical oncology.

The Lymphocyte in Hodgkin’s Disease: Has it Lost Its Way?

D. Crowther, J. Wagstaff, C. Gibson, 1984 .

The role of postoperative alkylating agent therapy in early‐stage epithelial ovarian cancer

D. Crowther, C. H. Buckley, M. Lind, 1989 .

CONTROLLED TRIAL OF ADJUVANT CHEMOTHERAPY WITH MELPHALAN FOR BREAST CANCER

R. K. Knight, A. Howell, I. Fentiman, 1983, The Lancet.

Early central nervous system involvement in adults with acute non-myelogenous leukaemia.

T. Lister, D. Crowther, P. Wrigley, 1977, British Journal of Cancer.

Metallothionein levels in ovarian tumours before and after chemotherapy.

D. Crowther, A. McGown, B. Fox, 1991, British Journal of Cancer.

Lack of prognostic value of the thymidine-labelling index in adult acute leukaemia.

T. Lister, D. Crowther, S. Johnson, 1981, British Journal of Cancer.

Comparative toxicity of cisplatin, carboplatin (CBDCA) and iproplatin (CHIP) in combination with cyclophosphamide in patients with advanced epithelial ovarian cancer.

D. Crowther, J. Mcgregor, J. Wagstaff, 1988, European journal of cancer & clinical oncology.

Effects of Corynebacterium parvum on cellular immunity of cancer patients, assayed sequentially over 63 days

D. Crowther, N. Thatcher, R. Swindell, 1981, Cancer.

Effects of BCG and Corynebacterium parvum on immune reactivity in melanoma patients.

D. Crowther, N. Thatcher, 1977, Developments in biological standardization.

The role of computed tomography in the management of ovarian tumours of borderline malignancy.

J. Radford, D. Crowther, C. H. Buckley, 1997, Clinical Radiology.

EORTC Group Phase II Study of Oral Etoposide for Pretreated Soft Tissue Sarcoma

O. S. Nielsen, H. Keizer, D. Crowther, 1997, Sarcoma.

Time-course of the recovery of cellular immune function after high-dose chemotherapy and peripheral blood progenitor cell transplantation for high-grade non-Hodgkin's lymphoma.

M. Ghielmini, P. Stern, J. Radford, 1995, Bone marrow transplantation.

The behavior of autologous indium-114m-labeled lymphocytes in patients with lymphoid cell malignancy.

D. Deakin, R. Cowan, D. Crowther, 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Anti‐T antibody in malignant melanoma patients. Influence of response and survival following chemotherapy—changes in serum levels following C parvum, BCG immunization

D. Crowther, N. Thatcher, R. Swindell, 1980, Cancer.

The EORTC Phase II study of iproplatin in advanced osteogenic sarcoma.

M. van Glabbeke, H. Keizer, D. Crowther, 1999, European Journal of Cancer.

Prognostic significance of pretreatment serum beta 2-microglobulin levels in multiple myeloma.

D. Crowther, M. Palmer, H. Anderson, 1983, European journal of cancer & clinical oncology.

5T4 oncofetal antigen expression in ovarian carcinoma

P. Stern, D. Crowther, R. Swindell, 1994, International Journal of Gynecologic Cancer.

The management of primary fallopian tube carcinoma

D. Crowther, H. Gurney, D. Murphy, 1990, British journal of obstetrics and gynaecology.

Short report: Weekly oral 4-demethoxydaunorubicin in patients with relapsed low grade non-Hodgkin's lymphoma

D. Crowther, W. Steward, David Smith, 1991 .

STAGTING PATIENTS WITH NON‐HODGKIN'S LYMPHOMA

D. Crowther, E. Rankin, D. Crowther, 1982 .

Phase II Evaluation in Patients with Non-Hodgkin’s Lymphoma the Old World Experience — An Interim Report

D. Crowther, J. Smyth, H. Høst, 1985 .

The “Hot spleen” phenomenon in metastatic malignant melanoma. Its incidence and relationship with the immune system

D. Crowther, N. Thatcher, K. Phadke, 1982, Cancer.

Effects of erythropoietin on mobilisation of haemopoietic progenitor cells.

D. Crowther, P. Woll, R. Pettengell, 1994, Bone Marrow Transplantation.

A phase I toxicity study of human rDNA interferon in patients with solid tumours

A. Howell, D. Crowther, N. Thatcher, 2004, Cancer Chemotherapy and Pharmacology.

Clinical studies with recombinant human granulocyte-macrophage colony-stimulating factor.

D. Crowther, W. Steward, J. Howard Scarffe, 1990, International journal of cell cloning.

Correlation of drug resistance-associated parameters in ovarian tumor biopsies

D. Crowther, R. Swindell, B. Fox, 1993, International Journal of Gynecologic Cancer.

A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease.

J. Armitage, V. Diehl, T. Lister, 1998, The New England journal of medicine.

The use of recombinant human granulocyte-macrophage colony-stimulating factor with combination chemotherapy in the treatment of advanced adult soft-tissue sarcomas: early results from the EORTC Soft-Tissue and Bone Sarcoma Group.

D. Crowther, J. Verweij, T. Tursz, 1993, Cancer chemotherapy and pharmacology.

Occurrence of a fetal fibroblast phenotype in familial breast cancer

A. Howell, D. Crowther, R. Sellwood, 1986, International journal of cancer.

Combination chemotherapy for advanced non-Hodgkin's lymphoma of unfavourable histology

T. Lister, A. Stansfeld, D. Crowther, 2004, Cancer Chemotherapy and Pharmacology.

Changes in nonspecific lymphoid (NK, K, T cell) cytotoxicity following BCG immunisation of healthy subjects

D. Crowther, N. Thatcher, 2004, Cancer Immunology and Immunotherapy.

Towards quality control in cancer chemotherapy.

D. Crowther, M. Nicolson, C. Woodman, 1996, British Journal of Cancer.

Medical Oncology: An Advanced Course

D. Crowther, 1981, British Journal of Cancer.

Effect of verapamil on daunorubicin accumulation in lymphocytes isolated from patients undergoing chemotherapy

D. Crowther, A. McGown, B. Fox, 2004, Cancer Chemotherapy and Pharmacology.

Autologous lymphocytes as vectors to target therapeutic radiation, using indium‐114m, in patients with lymphoid cell malignancy

R. Cowan, D. Crowther, S. Owens, 2002, British journal of haematology.

Phase I/II study of intraperitoneal iproplatin in patients with minimal residual disease following platinum-based systemic therapy for epithelial ovarian carcinoma.

D. Crowther, M. Ranson, D. Smith, 1992, European journal of cancer.

Combination chemotherapy for acute lymphoblastic leukaemia in adults.

J. E. Freeman, T. Lister, D. Crowther, 1978, British medical journal.

Cancer Therapy: Prognostic Factors and Criteria of Response

D. Crowther, 1977, British Journal of Cancer.

Colchicine ultrasensitivity of peripheral-blood lymphocytes from patients with non-Hodgkin's lymphoma.

D. Crowther, J. H. Scarffe, J. V. Garrett, 1980, British Journal of Cancer.